. . . . . . . . . . . . . . "p(MGI:Tgfb1) -| path(SDIS:\"Atherosclerotic lesion\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "inhibition of endogenous TGF-?1 signaling in mice using either neutralizing monoclonal antibodies or soluble recombinant TGF-? receptor type II (TGF-?RII) accelerated atherosclerotic lesion formation characterized by increased macrophages and T cells, and decreased collagen content.30, 31" . . "Selventa" . . . . "2014-07-03T14:32:56.033+02:00"^^ . . .